breast cancer kobe 6

Release time ：Dec-21,2024

Breast cancer is a prevalent malignant neoplasm with a global increasing trend in incidence. Timely detection and intervention are crucial for enhancing the survival rates of patients with breast cancer. Treatment options primarily consist of surgery, radiotherapy, chemotherapy, endocrine therapy, and targeted therapy. Surgery stands as the principal therapeutic approach, with the choice between breast-conserving surgery and total mastectomy depending on the specific condition of the disease. Radiotherapy and chemotherapy are predominantly employed to eradicate residual cancer cells, thereby minimizing the risk of recurrence. Endocrine and targeted therapies are tailored to certain breast cancer types, functioning by interrupting the growth signals of cancer cells to achieve therapeutic goals.

Prognosis in breast cancer is influenced by numerous factors, including tumor size, grade, lymph node involvement, and patient-specific factors such as age and genetic predisposition. Generally, early-stage breast cancer has a higher cure rate, while advanced stages pose greater treatment challenges and poorer prognoses. Additionally, breast cancer subtypes impact treatment outcomes and prognosis; for instance, HER2-positive breast cancer is more responsive to targeted therapies, whereas triple-negative breast cancer lacks effective targeted treatment options.

Routine health check-ups and breast cancer screenings are essential for patients with breast cancer. Any detected abnormalities should prompt immediate medical consultation for professional diagnosis and treatment. Throughout the treatment process, patients must adhere to prescribed medication regimens and avoid self-medicating without guidance. Moreover, maintaining healthy lifestyle practices, such as smoking cessation, alcohol moderation, balanced nutrition, and regular physical activity, can significantly contribute to improved treatment efficacy and overall quality of life.